Works matching AU Solh, Melhem

Results: 33

Efficacy and Safety Exposure–Response Analysis of Loncastuximab Tesirine in Patients with B cell non-Hodgkin Lymphoma.

Published in:

AAPS Journal, 2022, v. 24, n. 1, p. 1, doi. 10.1208/s12248-021-00660-3

By:

Hess, Brian;
Townsend, William;
Ai, Weiyun;
Stathis, Anastasios;
Solh, Melhem;
Alderuccio, Juan Pablo;
Ungar, David;
Liao, Sam;
Liao, Lori;
Khouri, Lisa;
Zhang, Xiaoyan;
Boni, Joseph

Publication type:

Article

Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation.

Published in:

British Journal of Haematology, 2021, v. 195, n. 5, p. 757, doi. 10.1111/bjh.17865

By:

Riedell, Peter A.;
Hamadani, Mehdi;
Ahn, Kwang W.;
Litovich, Carlos;
Brunstein, Claudio G.;
Cashen, Amanda F.;
Cohen, Jonathon B.;
Epperla, Narendranath;
Hill, Brian T.;
Im, Annie;
Inwards, David J.;
Lister, John;
McCarty, John M.;
Ravi Kiran Pingali, Sai;
Shadman, Mazyar;
Shaughnessy, Paul;
Solh, Melhem;
Stiff, Patrick J.;
Vose, Julie M.;
Kharfan-Dabaja, Mohamed A.

Publication type:

Article

P1132: LONG-TERM RESPONSES WITH LONCASTUXIMAB TESIRINE: UPDATED RESULTS FROM LOTIS-2, THE PIVOTAL PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA.

Published in:

2023

By:

Caimi, Paolo F;
Ai, Weiyun Z;
Pablo Alderuccio, Juan;
Ardeshna, Kirit M;
Hamadani, Mehdi;
Hess, Brian;
Kahl, Brad S;
Radford, John;
Solh, Melhem;
Stathis, Anastasios;
Luigi Zinzani, Pier;
Wang, Ying;
Qin, Yajuan;
Wang, Luqiang;
Xu, Cindy;
Carlo-Stella, Carmelo

Publication type:

Abstract

Posterior reversible encephalopathy syndrome following pembrolizumab therapy for relapsed Hodgkin’s lymphoma.

Published in:

Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 1, p. 71, doi. 10.1177/1078155215620922

By:

LaPorte, Justin;
Solh, Melhem;
Ouanounou, Serge

Publication type:

Article

A Phase II Trial of Melphalan Based Reduced-Intensity Conditioning for Transplantation of T-Replete HLA-Haploidentical Peripheral Blood Stem Cells with Posttransplant Cyclophosphamide in Patients with Hematologic Malignancies.

Published in:

Advances in Hematology, 2021, p. 1, doi. 10.1155/2021/8868142

By:

Solh, Melhem M.;
Hinojosa, Gabriel;
Laporte, Justin;
Solomon, Scott R.;
Morris, Lawrence E.;
Zhang, Xu;
Holland, H. Kent;
Bashey, Asad

Publication type:

Article

Myeloablative Conditioning with PBSC Grafts for T Cell-Replete Haploidentical Donor Transplantation Using Posttransplant Cyclophosphamide.

Published in:

Advances in Hematology, 2016, p. 1, doi. 10.1155/2016/9736564

By:

Solomon, Scott R.;
Solh, Melhem;
Morris, Lawrence E.;
Holland, H. Kent;
Bashey, Asad

Publication type:

Article

ONSET, DURATION, AND MANAGEMENT OF EDEMA AND EFFUSION IN PATIENTS TREATED WITH LONCASTUXIMAB TESIRINE FOR R/R DLBCL: UPDATED RESULTS FROM THE LOTIS-2 CLINICAL TRIAL.

Published in:

Oncology Nursing Forum, 2022, v. 49, n. 2, p. E56, doi. 10.1188/22.ONF.E2

By:

Grandas, Claudia;
Hendrickson, Lindsey;
Alderuccio, Juan Pablo;
Hess, Brian;
Ungar, David;
Solh, Melhem

Publication type:

Article

Plasma cell CD20 expression: primary aberrant expression or receptor up-regulation.

Published in:

2014

By:

Ajaz, Bushra;
Akhtar, Adnan;
Chang, Chung-Che;
Solh, Melhem;
Tangonan, Kay;
Khaled, Yasser

Publication type:

Case Study

Herpes zoster complicating bortezomib therapy of relapsed/refractory indolent B-cell and mantle cell lymphoma: an analysis of two phase II trials.

Published in:

Leukemia & Lymphoma, 2013, v. 54, n. 10, p. 2185, doi. 10.3109/10428194.2013.772294

By:

Solh, Melhem;
Fisher, Richard I.;
Goy, André;
de Vos, Sven;
Bernstein, Steven H.;
Esseltine, Dixie-Lee;
Neuwirth, Rachel;
Morrison, Vicki A.

Publication type:

Article

The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011).

Published in:

Leukemia & Lymphoma, 2013, v. 54, n. 2, p. 252, doi. 10.3109/10428194.2012.710327

By:

Solh, Melhem;
Rai, Kanti R.;
Peterson, Bercedis L.;
Kolitz, Jonathan E.;
Appelbaum, Frederick R.;
Tallman, Martin S.;
Belch, Andrew;
Larson, Richard A.;
Morrison, Vicki A.

Publication type:

Article

Receptor Characteristics of the Second Tumor in Synchronous Versus Metachronous Breast Cancer.

Published in:

American Surgeon, 2008, v. 74, n. 8, p. 702, doi. 10.1177/000313480807400806

By:

Bu-Ali, Hanadi;
Solh, Melhem;
Kapur, Arthi;
Mittal, Vijay

Publication type:

Article

Core-binding factor acute myeloid leukemia: Heterogeneity, monitoring, and therapy.

Published in:

American Journal of Hematology, 2014, v. 89, n. 12, p. 1121, doi. 10.1002/ajh.23821

By:

Solh, Melhem;
Yohe, Sophia;
Weisdorf, Daniel;
Ustun, Celalettin

Publication type:

Article

Acquired Glanzmann's thrombasthenia with optimal response to rituximab therapy.

Published in:

American Journal of Hematology, 2011, v. 86, n. 8, p. 715, doi. 10.1002/ajh.22079

By:

Solh, Melhem;
Mescher, Craig;
Klappa, Anthony;
Shah, Surbhi;
Zantek, Nicole;
Datta, Yvonne

Publication type:

Article

Impact of bortezomib‐based versus lenalidomide maintenance therapy on outcomes of patients with high‐risk multiple myeloma.

Published in:

Cancer (0008543X), 2023, v. 129, n. 14, p. 2179, doi. 10.1002/cncr.34778

By:

Bumma, Naresh;
Dhakal, Binod;
Fraser, Raphael;
Estrada‐Merly, Noel;
Anderson, Kenneth;
Freytes, César O.;
Hildebrandt, Gerhard C.;
Holmberg, Leona;
Krem, Maxwell M.;
Lee, Cindy;
Lekakis, Lazaros;
Lazarus, Hillard M.;
Mian, Hira;
Murthy, Hemant S.;
Nathan, Sunita;
Nishihori, Taiga;
Parrondo, Ricardo;
Patel, Sagar S.;
Solh, Melhem;
Strouse, Christopher

Publication type:

Article

African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United States.

Published in:

Cancer (0008543X), 2021, v. 127, n. 1, p. 82, doi. 10.1002/cncr.33208

By:

Badar, Talha;
Hari, Parameswaran;
Dávila, Omar;
Fraser, Raphael;
Wirk, Baldeep;
Dhakal, Binod;
Freytes, Cesar O.;
Rodriguez Valdes, Cesar;
Lee, Cindy;
Vesole, David H.;
Malek, Ehsan;
Hildebrandt, Gerhard C.;
Landau, Heather;
Murthy, Hemant S.;
Lazarus, Hillard M.;
Berdeja, Jesus G.;
Meehan, Kenneth R.;
Solh, Melhem;
Diaz, Miguel Angel;
Kharfan‐Dabaja, Mohamed A.

Publication type:

Article

Correction: Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysis.

Published in:

2021

By:

Shah, Nirav N.;
Ahn, Kwang Woo;
Litovich, Carlos;
Sureda, Anna;
Kharfan-Dabaja, Mohamed A.;
Awan, Farrukh T.;
Ganguly, Siddhartha;
Gergis, Usama;
Inwards, David;
Karmali, Reem;
Lazaryan, Alexsandr;
Lekakis, Lazaros;
Munshi, Pashna;
Nathan, Sunita;
Saad, Ayman A.;
Solh, Melhem;
Steinberg, Amir;
Vij, Ravi;
Wood, William A.;
Fenske, Timothy S.

Publication type:

Correction Notice

Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysis.

Published in:

Blood Cancer Journal, 2019, v. 9, n. 12, p. 1, doi. 10.1038/s41408-019-0261-1

By:

Shah, Nirav N.;
Ahn, Kwang Woo;
Litovich, Carlos;
Sureda, Anna;
Kharfan-Dabaja, Mohamed A.;
Awan, Farrukh T.;
Ganguly, Siddhartha;
Gergis, Usama;
Inwards, David;
Karmali, Reem;
Lazaryan, Alexsandr;
Lekakis, Lazaros;
Munshi, Pashna;
Nathan, Sunita;
Saad, Ayman A.;
Solh, Melhem;
Steinberg, Amir;
Vij, Ravi;
Wood, William A.;
Fenske, Timothy S.

Publication type:

Article

De Novo CD3 Negative Hepatosplenic T-cell Lymphoma: Diagnostic Challenges and Pitfalls.

Published in:

2014

By:

Harn Kapur, Lucy;
Khaled, Yasser;
Solh, Melhem;
Ward, David;
Chung-Che Chang

Publication type:

Journal Article

De Novo CD3 Negative Hepatosplenic T-cell Lymphoma: Diagnostic Challenges and Pitfalls.

Published in:

Archives of Pathology & Laboratory Medicine, 2014, v. 138, n. 7, p. 969, doi. 10.5858/arpa.2013-0074-CR

By:

Harn Kapur, Lucy;
Khaled, Yasser;
Solh, Melhem;
Ward, David;
Chung-Che Chang

Publication type:

Article

Glanzmann's thrombasthenia: pathogenesis, diagnosis, and current and emerging treatment options.

Published in:

Journal of Blood Medicine, 2015, v. 6, p. 219, doi. 10.2147/JBM.S71319

By:

Solh, Tia;
Botsford, Ashley;
Solh, Melhem

Publication type:

Article

Safety and Efficacy of Ruxolitinib in Patients with Myelofibrosis and Low Platelet Counts (50 - 100 x 10<sup>9</sup>/L): Final Analysis of an Open-Label Phase 2 Study.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 5, p. 336, doi. 10.1016/j.clml.2021.10.016

By:

Caimi, Paolo F.;
Ardeshna, Kirit M.;
Reid, Erin;
Ai, Weiyun;
Lunning, Matthew;
Zain, Jasmine;
Solh, Melhem;
Kahl, Brad S.;
Hamadani, Mehdi

Publication type:

Article

OAB-026: MagnetisMM-1 study of elranatamab (PF-06863135), a B-cell maturation antigen (BCMA) targeted CD3-engaging bispecific molecule, for patients (pts) with relapsed or refractory multiple myeloma (MM).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S17, doi. 10.1016/S2152-2650(21)02100-5

By:

Dholaria, Bhagirathbhai;
Bahlis, Nizar;
Raje, Noopur;
Costello, Caitlin;
Solh, Melhem;
Levy, Moshe;
Tomasson, Michael;
Dube, Harman;
Damore, Michael;
Hoi Kei Lon;
Basu, Cynthia;
Skoura, Athanasia;
Chan, Edward;
Trudel, Suzanne;
Jakubowiak, Andrzej;
Chu, Michael;
Gasparetto, Cristina;
Dalovisio, Andrew;
Sebag, Michael;
Lesokhin, Alexander

Publication type:

Article

MM-379: MagnetisMM-1: A Study of Elranatamab (PF-06863135), a B-Cell Maturation Antigen (BCMA)-Targeted, CD3-Engaging Bispecific Antibody, for Patients with Relapsed or Refractory Multiple Myeloma (MM).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S439, doi. 10.1016/S2152-2650(21)01978-9

By:

Levy, Moshe;
Bahlis, Nizar;
Raje, Noopur;
Costello, Caitlin;
Dholaria, Bhagirathbhai;
Solh, Melhem;
Tomasson, Michael;
Dube, Harman;
Damore, Michael;
Hoi Kei Lon;
Basu, Cynthia;
Skoura, Athanasia;
Chan, Edward;
Trudel, Suzanne;
Jakubowiak, Andrzej;
Chu, Michael;
Gasparetto, Cristina;
Dalovisio, Andrew;
Sebag, Michael;
Lesokhin, Alexander

Publication type:

Article

ABCL-396: Incidence, Onset, and Management of Edema and Effusion in Patients Treated with Loncastuximab Tesirine for R/R DLBCL in the LOTIS Clinical Trial Program.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S397, doi. 10.1016/S2152-2650(21)01899-1

By:

Alderuccio, Juan Pablo;
Ardeshna, Kirit;
Hess, Brian;
Radford, John;
Lunning, Matt;
Ungar, David;
Burke, Muneet;
Luqiang Wang;
Solh, Melhem

Publication type:

Article

ABCL-362: Incidence, Onset, and Management of Myelosuppression in Patients Treated with loncastuximab Tesirine for R/R DLBCL in a Pooled Safety Analysis.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S394, doi. 10.1016/S2152-2650(21)01894-2

By:

Solh, Melhem;
Alderuccio, Juan Pablo;
Hess, Brian;
Radford, John;
Lunning, Matt;
Ungar, David;
Burke, Muneet;
Wang, Luqiang;
Ardeshna, Kirit

Publication type:

Article

ABCL-022: LOTIS-2 Follow-Up Analysis: Updated Results from a Phase 2 Study of Loncastuximab Tesirine (Lonca) in Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S377, doi. 10.1016/S2152-2650(21)01861-9

By:

Kahl, Brad S.;
Hamadani, Mehdi;
Caimi, Paolo F.;
Carlo-Stella, Carmelo;
Weiyun Ai;
Alderuccio, Juan Pablo;
Ardeshna, Kirit M.;
Hess, Brian;
Radford, John;
Solh, Melhem;
Stathis, Anastasios;
Feingold, Jay;
Ungar, David;
Yajuan Qin;
Shui He;
Zinzani, Pier Luigi

Publication type:

Article

Poster: MM-379: MagnetisMM-1: A Study of Elranatamab (PF-06863135), a B-Cell Maturation Antigen (BCMA)-Targeted, CD3-Engaging Bispecific Antibody, for Patients with Relapsed or Refractory Multiple Myeloma (MM).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S252, doi. 10.1016/S2152-2650(21)01578-0

By:

Levy, Moshe;
Bahlis, Nizar;
Raje, Noopur;
Costello, Caitlin;
Dholaria, Bhagirathbhai;
Solh, Melhem;
Tomasson, Michael;
Dube, Harman;
Damore, Michael;
Lon, Hoi Kei;
Basu, Cynthia;
Skoura, Athanasia;
Chan, Edward;
Trudel, Suzanne;
Jakubowiak, Andrzej;
Chu, Michael;
Gasparetto, Cristina;
Dalovisio, Andrew;
Sebag, Michael;
Lesokhin, Alexander

Publication type:

Article

Poster: ABCL-396: Incidence, Onset, and Management of Edema and Effusion in Patients Treated with Loncastuximab Tesirine for R/R DLBCL in the LOTIS Clinical Trial Program.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S238, doi. 10.1016/S2152-2650(21)01498-1

By:

Alderuccio, Juan Pablo;
Ardeshna, Kirit;
Hess, Brian;
Radford, John;
Lunning, Matt;
Ungar, David;
Burke, Muneet;
Luqiang Wang;
Solh, Melhem

Publication type:

Article

Poster: ABCL-362: Incidence, Onset, and Management of Myelosuppression in Patients Treated with loncastuximab Tesirine for R/R DLBCL in a Pooled Safety Analysis.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S238, doi. 10.1016/S2152-2650(21)01497-X

By:

Solh, Melhem;
Alderuccio, Juan Pablo;
Hess, Brian;
Radford, John;
Lunning, Matt;
Ungar, David;
Burke, Muneet;
Luqiang Wang;
Ardeshna, Kirit

Publication type:

Article

Poster: ABCL-022: LOTIS-2 Follow-Up Analysis: Updated Results from a Phase 2 Study of Loncastuximab Tesirine (Lonca) in Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S238, doi. 10.1016/S2152-2650(21)01495-6

By:

Kahl, Brad S.;
Hamadani, Mehdi;
Caimi, Paolo F.;
Carlo-Stella, Carmelo;
Weiyun Ai;
Alderuccio, Juan Pablo;
Ardeshna, Kirit M.;
Hess, Brian;
Radford, John;
Solh, Melhem;
Stathis, Anastasios;
Feingold, Jay;
Ungar, David;
Yajuan Qin;
Shui He;
Zinzani, Pier Luigi

Publication type:

Article

Oral Abstract: ABCL-022: LOTIS-2 Follow-Up Analysis: Updated Results from a Phase 2 Study of Loncastuximab Tesirine (Lonca) in Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S203, doi. 10.1016/S2152-2650(21)01278-7

By:

Kahl, Brad S.;
Hamadani, Mehdi;
Caimi, Paolo F.;
Carlo-Stella, Carmelo;
Ai, Weiyun;
Alderuccio, Juan Pablo;
Ardeshna, Kirit M.;
Hess, Brian;
Radford, John;
Solh, Melhem;
Stathis, Anastasios;
Feingold, Jay;
Ungar, David;
Qin, Yajuan;
He, Shui;
Zinzani, Pier Luigi

Publication type:

Article

Blood transfusions and pulmonary complications after hematopoietic cell transplantation.

Published in:

2016

By:

Solh, Melhem;
Morgan, Shanna;
McCullough, Jeffrey;
Shanley, Ryan;
Weisdorf, Daniel J.

Publication type:

journal article

Autoimmune Demyelinating Polyneuropathy as a Manifestation of Chronic Graft-versus-Host Disease after Adult Cord Blood Transplantation in a Patient with Chronic Lymphocytic Leukemia.

Published in:

2014

By:

Hogan, Fredrick;
Solh, Melhem

Publication type:

Case Study